denbufylline has been researched along with Alzheimer Disease in 2 studies
denbufylline: structure given in first source
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saletu, B | 1 |
| Anderer, P | 1 |
| Fischhof, PK | 1 |
| Lorenz, H | 1 |
| Barousch, R | 1 |
| Böhmer, F | 1 |
| Nicholson, CD | 1 |
1 review available for denbufylline and Alzheimer Disease
| Article | Year |
|---|---|
Nootropics and metabolically active compounds in Alzheimer's disease.
Topics: Aged; Alkaloids; Alzheimer Disease; Animals; Humans; Learning; Memory; Piracetam; Psychotropic Drugs | 1989 |
1 trial available for denbufylline and Alzheimer Disease
| Article | Year |
|---|---|
EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Attention; Brain Mapping; Cerebral Cortex; Dementia, Mul | 1992 |